Clinical Trial Update: A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma [Phase 1]

View source ↗

Summary

The Phase I trial of normothermic isolated limb infusion with melphalan plus buthionine sulfoximine (BSO) for locally advanced malignant melanoma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Buthionine sulfoximine (buthionine sulfoximine)
• Melphalan (Melphalan)

Snippet

Sponsor: Duke University | Conditions: Melanoma (Skin) | Phase 1 | Status: WITHDRAWN